Sugar Editorial Picks
Sep 24, 2008 -
Feeling stressed? It could be a sign of the times or it could also be a sign of where you live. Some cities are more stressful than others, and Forbes has outlined the top 10 most stressful cities in the US.
- 23 Comments
Other Search Results
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- The Body's Response
- Complications
- Conditions with Similar Sym...
- Treatment
- Risk Factors
- Lifestyle Changes
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
- Some people are pre-programmed for a heightened response to stress by conditions in the womb. Pregnant women under stress who eat a diet high in protein and low in carbohydrates have babies with higher cortisol levels. Later on, these levels increase in response to stress.
- The impact of stress on the heart and circulation system is becoming more clear.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Complications
- Diagnosis
- Treatment
- Medications
- Other Treatments
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approval
In 2007, duloxetine (Cymbalta) was approved for treatment of generalized anxiety disorder. Duloxetine is a dual inhibitor antidepressant.
Anxiety Disorders Under-Recognized and Under-Treated
About 41% of patients with an anxiety disorder do not receive any treatment, indicates a 2007 study in the Annals of Internal Medicine.
- 1 Comment
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Prognosis
- Risk Factors
- Symptoms
- Diagnosis
- Treatment
- Quick-Relief Medications...
- Long-Term Relief Medication...
- Other Treatments
- Managing Asthma
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Warning
In 2007, the FDA requested the manufacturers of omalizumab (Xolair) to include a “boxed warning” emphasizing that this drug may cause a severe and life-threatening allergic reaction (anaphylaxis). Health care providers need to carefully observe patients for 2 hours after they receive an omalizumab injection. However, because an allergic reaction can occur up to 24 hours after the injection, patients need to know the signs and symptoms of anaphylaxis and how to self-administer emergency treatment.
- 0 Comments
Oct 08, 2008 -
Overview
- Signs and Symptoms
- Causes
- Risk Factors
- Diagnosis
- Prevention
- Treatment
- Other Considerations
- Supporting Research
HEALTH GUIDE REFERENCE FROM A.D.A.M
Asthma is a chronic disease that involves inflammation of the lungs. Airways swell and restrict airflow in and out of the lungs, making it hard to breathe. The word asthma comes from the Greek word for "panting."
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Complications
- Risk Factors
- Diagnosis
- Dietary Factors
- Symptom Management
- Medications
- Surgery
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Biologic Drugs
- In February 2007, the FDA approved adalimumab (Humira) for treatment of adult patients with moderate-to-severe Crohn’s disease. Adalimumab and infliximab (Remicade) are now the two biologic drugs approved for Crohn’s disease. Infliximab is approved for treating both adults and children.
- As of August 2007, the FDA was considering approving natalizumab (Tysabri) for moderate-to-severe Crohn’s disease in patients who have not responded to, or cannot tolerate, other therapies.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Considerations
- Male Contraception
- Surgery
- Complications
- Unexpected Pregnancy
- Long-Term Complications
- Reversal Surgery
- Assisted Reproductive Techn...
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Search Continues for the "Male Pill"
Research is progressing on a male contraceptive, but there have also been setbacks. The drug miglustat (Zavesca), which is used to treat a rare condition called Gaucher's disease, had shown success in animal studies but failed to work in a clinical trial, according to results published in 2007 in Human Reproduction. Researchers are now investigating an experimental drug, Adjudin (AF-2364), which disrupts sperm production.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Symptoms
- Risk Factors
- Prognosis
- Diagnosis
- Treatment
- Vaccinations
- Prevention
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
West Nile Virus
In 2007, 3,510 cases of West Nile virus were reported to the U.S. Centers for Disease Control. States with the highest number of reported cases included Colorado, California, and North Dakota.
- 0 Comments
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Complications
- Diagnosis
- Treatment for Alcoholism...
- Treatment for Alcohol Withd...
- Therapy
- Medications
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Research
Topiramate (Topamax), an anticonvulsant drug used to treat epilepsy, is showing promise as a treatment for alcohol dependence. In a 2007 study published in the Journal of the American Medical Association, patients who took topiramate had fewer heavy drinking days, fewer drinks per day, and more days of not drinking at all than patients who received placebo.
Alcohol and Heart Disease
Heart disease is one of the leading causes of death among people who are heavy drinkers.
- 1 Comment
Oct 08, 2008 -
In This Report
- Highlights
- Introduction
- Causes
- Risk Factors
- Symptoms
- Complications
- Diagnosis
- Treatment
- Medications
- Therapy
- Other Treatments
- Resources
- References
HEALTH GUIDE REFERENCE FROM A.D.A.M
Highlights
Drug Approvals
- In 2007, the Food and Drug Administration approved risperidone (Risperdal) and aripiprazole (Abilify) for treatment schizophrenia in teenagers. These drugs are the first atypical antipsychotics approved specifically for children.
- Paliperidone (Invega) is the newest atypical antipsychotic drug approved for treatment of schizophrenia in adults. Paliperidone is chemically related to risperidone.
Diabetes Risk and Atypical Antipsychotics
- In 2007, the manufacturer of olanzapine (Zyprexa, Symbex) added new warnings to the drug’s prescribing label.
- 0 Comments